Dr. Anna Nikolaidou | Nanomedicine | Best Researcher Award

Dr. Anna Nikolaidou, National and Kapodistrian University of Athens, Greece

Dr. Anna Nikolaidou 🩺✨ is a Greek ophthalmologist and researcher specializing in nanomedicine and retinal diseases. Currently a Myopia Research Fellow in Tübingen, Germany 🇩🇪, she explores the visual impact of removing chromatic aberration in emmetropes and myopes. With an MD from Aristotle University of Thessaloniki (graduated with honors 🎓), she holds two MSc degrees focusing on medical research methodology and nanomedicine. Dr. Nikolaidou has published in renowned journals, combining artificial intelligence 🤖 and teleophthalmology 📡 to advance retinal disease diagnosis. Her innovative work bridges cutting-edge science and patient care 🌟, making her a rising leader in ophthalmology.

Professional Profile:

Scopus

Orcid

Suitability Summary

Dr. Anna Nikolaidou is an exemplary candidate for the Best Researcher Award due to her outstanding contributions to ophthalmology, nanomedicine, and retinal disease research. Her pioneering work bridges cutting-edge science, such as nanotechnology and artificial intelligence (AI), with clinical practice, advancing diagnosis, treatment, and care for complex eye conditions. With multiple academic achievements, prestigious research fellowships, and innovative projects in AI-based retinal disease diagnosis and nanomedicine, Dr. Nikolaidou has demonstrated leadership, innovation, and impact in her field.

Education and Experience

🎓 MSc in Nanomedicine (2023 – Ongoing)
Thesis: Utilization of Nanoparticles for Treating Age-related Macular Degeneration.
🎓 MSc in Medical Research Methodology (2021 – 2023)
Thesis: AI Algorithms for Retinopathy of Prematurity Diagnosis.
🎓 Doctor of Medicine (MD) (2015 – 2021)
Aristotle University of Thessaloniki – Graduated Excellent (9.47/10).
🩺 Myopia Research Fellow (2024 – Present)
Institute of Ophthalmic Research, Tübingen, Germany.
👁️ Ophthalmology Resident (2023 – 2024)
Aghia Sophia Children’s Hospital, Greece.
🔬 Research Fellow (2022 – 2023)
LIFE4LV Project (ClinicalTrials.gov Identifier: NCT05184036).

Professional Development

Dr. Nikolaidou’s career integrates innovation and research 🌐. She has contributed to AI-based retinal disease diagnosis 🤖 and teleophthalmology 📡, enhancing ophthalmic care post-COVID-19. At Moorfields Eye Hospital, she studied medical retina and genetics 🔬. Her award-winning work includes systematic reviews on glaucoma management and space medicine. Through conference presentations 🎤 at prestigious platforms, including the American Academy of Ophthalmology 🇺🇸, and publications in high-impact journals 📚, she continues to shape the future of eye care. Dr. Nikolaidou’s passion for nanotechnology and theranostics demonstrates her commitment to blending science and clinical practice for global health 🌍.

Research Focus

Dr. Nikolaidou focuses on nanomedicine 🧬, applying nanoparticles for retinal disease treatment. Her research delves into AI algorithms 🤖 for diagnosis, particularly retinopathy of prematurity and space medicine 🚀. At the forefront of ophthalmology, she examines the removal of chromatic aberration for better visual outcomes 👁️. Her innovative projects emphasize theranostics 🩻, integrating diagnostics and treatment. Through interdisciplinary collaboration 🌐, she contributes to advancing retinal care, leveraging teleophthalmology 📡 and cutting-edge imaging technologies 🖥️. With a commitment to addressing complex eye conditions, her work aims to improve diagnosis, management, and patient outcomes globally 🌍.

Awards and Honors

🏆 Presented research at the American Academy of Ophthalmology and European Pediatric Ophthalmology Congress.
🥇 Recognized for innovative AI-based research on retinal diseases and space medicine.
🏅 Published impactful studies in prestigious journals like Journal of Glaucoma and Brain & Development.
🌟 Honored for contributions to teleophthalmology and post-COVID ophthalmic care strategies.

Publication Top Notes:

Virtual Reality With Eye Tracking for Pediatric Ophthalmology: A Systematic Review
📄 The Effect of Phacoemulsification on the Intraocular Pressure of Patients With Open Angle Glaucoma: A Systematic Review and Meta-Analysis

🔗 2 Citations
📄 Neuropsychiatric manifestations associated with Juvenile Systemic Lupus Erythematosus: An overview focusing on early diagnosis

🔗 2 Citations
📄 Investigation of Sleep Quality and Mental Health of Greek Physicians During the COVID-19 Pandemic
📄 Microgravity induced resting state networks and metabolic alterations during sleep onset

🔗 1 Citation

Prof. Kang-Ho Choi, Chonnam National University Medical School and Hospital, South Korea

Dr. Kang-ho Choi is an esteemed Associate Professor in the Department of Neurology at Chonnam National University Hospital, Gwangju, Korea. He earned his M.D. from Chonnam National University Medical School in 2005, followed by a Ph.D. from the same institution in 2011. Dr. Choi completed extensive postgraduate training, including fellowships at Hanyang University Medical Center and Bristol University. His research and clinical expertise focus on neurology, with notable contributions in stroke and neurodegenerative diseases. Dr. Choi has received numerous awards for his research and clinical excellence, including multiple “Best Investigator” and “Best Poster Presentation” awards. He is a member of various professional organizations, including the Korean Neurological Association and the American Heart Association/American Stroke Association.

Professional Profile:

Scopus

Evaluation of Kangho Choi, M.D., Ph.D. for the Best Researcher Award

Summary of Suitability for Award:

Dr. Kangho Choi is a distinguished researcher in the field of neurology with an impressive track record of achievements that make him a highly suitable candidate for the Best Researcher Award

🎓Education:

Dr. Kang-ho Choi completed his medical education at Chonnam National University Medical School in Gwangju, Korea, where he earned his M.D. degree from March 1999 to February 2005. He continued his academic journey at Chonnam National University Graduate School, obtaining his Master’s degree (M.S.) from March 2006 to February 2008, and later his Ph.D. from March 2009 to February 2011.

🏢Work Experience:

Dr. Kang-ho Choi has held several key positions in his career. Since November 2016, he has been serving as an Associate Professor in the Department of Neurology at Chonnam National University Hospital in Gwangju, Korea. Prior to this role, he was an Assistant Professor in the same department from March 2011 to October 2016. Dr. Choi completed his Clinical Fellowship at Chonnam National University Hospital from March 2010 to February 2011, and also undertook Research Fellowships at Hanyang University Medical Center in Seoul, Korea, from November 2010 to December 2010, and at the School of Clinical Sciences, Bristol University in the United Kingdom, from March 2013 to June 2013. His foundational training includes a Residency in Neurology at Chonnam National University Hospital from March 2006 to February 2010 and a Medical Internship at the same institution from March 2005 to February 2006.

🏅Awards:

Dr. Kang-ho Choi has received numerous prestigious awards throughout his career, reflecting his significant contributions to neurology. He was honored with the Best Investigator Award from Chonnam National University Hospital in December 2019 and May 2022. Additionally, he received the Break-through of the Year award from KHIDI of Korea in December 2017 and from the NRF of Korea in December 2020. In July 2017, he earned the Young Investigator Award at the Hwasun Biomedical Workshop. Dr. Choi’s excellence in research presentations is highlighted by multiple Best Poster Presentation Awards, including those from the ICSU & ICAS Joint Conference in September 2016, the ICSU 2018 & 1st AKJSC Joint Conference in September 2018, Stroke Update 2023 & 11th JKJSC in November 2023, and APSC 2023 in December 2023. His accolades also include the Best Presentation Award at the 35th Conference of KNA in November 2016, the Best Article award at the Annual Meeting of the Korean Neurological Association in October 2009, and the Best Doctor of the Year award from Chonnam National University Hospital in February 2010. Earlier in his career, he was recognized as the Best Resident of the Year by The Korean Intern Resident Association in February 2007.

Publication Top Notes:

Focused Magnetic Stimulation for Motor Recovery After Stroke
Treatment of Ischemic Stroke by Atorvastatin-Loaded PEGylated Liposome
Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke
Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
Erratum: Corrigendum to “D-dimer to Fibrinogen Ratio Predicts Early Neurological Deterioration in Ischemic Stroke with Atrial Fibrillation”